A phase I/II trial of high-dose radioimmunotherapy (RIT) with Zevalin in combination with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous stem cell transplant (ASCT) in patients with poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Nademanee, A
Molina, A
Forman, SJ
Kogut, N
Yamauchi, D
An, L
White, CA
Raubitschek, A
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Kaiser Permanente City Hope, Bone Marrow Transplant Program, Duarte, CA 91010 USA
[3] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
679
引用
收藏
页码：182A / 182A
页数：1
相关论文
共 50 条
  • [21] High-dose therapy and stem cell transplantation (BMT) for relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Shahidi, H
    Gregory, SA
    GuptaBurt, S
    Adler, SS
    Venugopal, P
    Meyer, P
    Korenblit, AD
    Recine, D
    Manson, S
    Kaizer, H
    BLOOD, 1997, 90 (10) : 1023 - 1023
  • [22] Multicenter phase II trial of 90Y-Ibritumomab tiuxetan with high-dose chemotherapy (busulfan/cyclophosphamide/etoposide) followed by autologous stem cell transplantation in relapsed, refractoried, or high-risk B-cell NHL
    Kang, Byung Woog
    Jo, Jae-Cheol
    Kim, Shin
    Jang, Geundoo
    Lee, Sung Sook
    Sym, Sun Jin
    Ryu, Jin-Sook
    Kim, Won Seog
    Yoon, Sung Soo
    Suh, Cheolwon
    BLOOD, 2007, 110 (11) : 569A - 569A
  • [23] Multicentre phase II trial of 90Y-ibritumomab tiuxetan with high-dose chemotherapy (busulfan/cyclophosphamide/etoposide) followed by autologous stem cell transplantation in relapsed, refractory, or high-risk B-cell NHL
    Kang, B. W.
    Kim, S.
    Cho, Y. H.
    Ryu, J. -S.
    Kim, W. S.
    Yoon, S. S.
    Suh, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S248 - S248
  • [24] Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
    Oki, Yasuhiro
    Ogura, Michinori
    Kato, Harumi
    Kikuchi, Ako
    Taji, Hirofumi
    Kagami, Yoshitoyo
    Oshiro, Aya
    Tsujimura, Akane
    Yamamoto, Kazuhito
    Morishima, Yasuo
    CANCER SCIENCE, 2008, 99 (01) : 179 - 184
  • [25] Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma
    Robertson, MJ
    Abonour, R
    Hromas, R
    Nelson, RP
    Fineberg, NS
    Cornetta, K
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1477 - 1487
  • [26] Autologous hematopoietic stem cell transplantation (ASCT) outcomes in non-Hodgkin lymphoma (NHL) patients undergoing high dose therapy (HDT) with etoposide, cyclophosphamide and thiotepa (VP/CY/TT) versus cyclophosphamide, carmustine and etoposide (CBV)
    Veltri, L. W.
    Shah, N.
    Cumpston, A.
    Zhang, J.
    Wen, S.
    Watkins, K.
    Leadmon, S.
    Craig, M.
    Hamadani, M.
    Kanate, A. S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S238 - S238
  • [27] Phase I trial of 90Y-ibritumomab tiuxetan in patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation
    Vose, Julie M.
    Bierman, Philip J.
    Loberiza, Fausto R., Jr.
    Bociek, Robert G.
    Matso, Daniel
    Armitage, James O.
    LEUKEMIA & LYMPHOMA, 2007, 48 (04) : 683 - 690
  • [28] High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
    Gopal, AK
    Gooley, TA
    Maloney, DG
    Petersdorf, SH
    Eary, JF
    Rajendran, JG
    Bush, SA
    Durack, LD
    Golden, J
    Martin, PJ
    Matthews, DC
    Appelbaum, FR
    Bernstein, ID
    Press, OW
    BLOOD, 2003, 102 (07) : 2351 - 2357
  • [29] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643
12345